FDA Seeks Right Touch For Next-Gen Sequencing With Standards Groups
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency and other policymakers see a strong role for third-party standards in supervision of next-generation sequencing as they explore the best role for FDA in the space over the long term.